Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTaking half a dose of Wegovy is not recommended and is not something the pen is designed to allow. Wegovy's pre-filled pens deliver a fixed, pre-set amount of semaglutide: there is no dial, no split function, and no reliable way to administer a partial dose. If nausea or another side effect is making you consider this, that's a conversation to have with your prescriber before adjusting anything yourself. These are prescription-only medicines, and any change to how you take them should be made by the clinician overseeing your care.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
You're a few weeks into treatment, the nausea hit harder than you expected, and someone online suggested taking half a dose next time. It sounds logical. If 0.5 mg caused this, surely 0.25 mg would be easier to tolerate?
The problem is mechanical, not just clinical. Wegovy's auto-injector pen is factory-set to release its entire cartridge in one press. There is no graduated scale, no half-way stop, and the needle retracts automatically once the injection cycle completes. You cannot physically pause it mid-dose and get a reliable, measured amount. Attempts to do so (withdrawing early, pressing and releasing) produce unpredictable results, not a controlled lower dose.
The NHS semaglutide medicines page is clear that semaglutide should be taken exactly as directed by your doctor or pharmacist, and the patient information leaflet reinforces that the pen delivers one fixed amount per injection. If you want to understand how the full dose schedule is structured, the Wegovy doses guide walks through each step and what to expect at every stage.
Wegovy's step-up design (starting at 0.25 mg and moving through 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg, with the newer 7.2 mg maintenance dose now also available) is not arbitrary. Each lower rung exists precisely because the body needs time to adjust to semaglutide's effects on gastric emptying and appetite signalling. The starter dose is there to settle your system, not to produce weight loss. GI symptoms are usually most noticeable just after starting or moving up; for most people they ease within a couple of weeks.
In other words, the schedule already anticipates what you're trying to achieve by halving your dose. If side effects are significant at your current step, the clinical answer is usually to pause the titration (staying at the same dose for an extra four weeks rather than moving up) rather than taking less than prescribed. That's a decision your prescriber makes with you, not something to resolve with a needle held halfway.
It's also worth knowing that the question of whether you can half-dose Wegovy comes up often enough that our clinical team addresses it directly in their prescribing consultations. You're not alone in wondering.
Beyond the question of whether it's possible, there are real safety reasons to leave dose decisions to your prescriber. Semaglutide has a long half-life (it stays active in the body for around a week) so inconsistent dosing can create unpredictable blood levels rather than the smooth, steady exposure the schedule is designed for. Irregular dosing can also make it harder to tell whether a side effect is the medicine or something else entirely.
Practically, attempting to stop an auto-injector mid-cycle risks the needle moving, the skin pulling, or the dose spraying rather than depositing subcutaneously. Pen damage is also possible. Your pen lives in the fridge between injections; taking it out, attempting a partial injection, and returning a compromised pen to use again raises questions about sterility and remaining function that the manufacturer simply hasn't tested for. If you're unsure whether injecting half a dose of Wegovy is even physically achievable with the pen you've been given, our clinical team has looked at this in detail.
The MHRA's Yellow Card scheme exists partly so that real-world experiences with medicines (including unexpected effects from altered dosing) are captured and reviewed. If something has gone wrong, reporting it matters.
If cost is part of the picture, it's worth reading about what Wegovy actually costs in the UK and what legitimate private treatment includes, rather than trying to stretch a pen further than it's designed to go.
The most effective thing you can do is contact your prescriber before your next injection day, not after. At nume, our prescribers are available seven days a week precisely for moments like this. A real clinician reviews your situation; they can adjust your titration plan, suggest practical steps (smaller meals, eating more slowly, staying upright after eating), or reassess whether the current dose is the right one for you right now.
If you're switching from another treatment and wondering whether your previous dose affects where you start on Wegovy, the guide on switching from Saxenda to Wegovy covers how dose transitions are handled clinically. And if you're curious about the broader picture of how treatment works, the Wegovy overview is a good place to start.
The short version: don't split the dose. Tell your prescriber what's happening. There are real, licensed options for managing tolerability, none of which involve guessing at fractions from a pen that wasn't built to give them.
If you'd like to discuss your options with a GPhC-registered prescriber, speak to our prescribers through a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.